JP2009215293A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009215293A5 JP2009215293A5 JP2009052853A JP2009052853A JP2009215293A5 JP 2009215293 A5 JP2009215293 A5 JP 2009215293A5 JP 2009052853 A JP2009052853 A JP 2009052853A JP 2009052853 A JP2009052853 A JP 2009052853A JP 2009215293 A5 JP2009215293 A5 JP 2009215293A5
- Authority
- JP
- Japan
- Prior art keywords
- ziprasidone
- dosage form
- oral dosage
- solid oral
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- MVWVFYHBGMAFLY-UHFFFAOYSA-N ziprasidone Chemical compound C1=CC=C2C(N3CCN(CC3)CCC3=CC=4CC(=O)NC=4C=C3Cl)=NSC2=C1 MVWVFYHBGMAFLY-UHFFFAOYSA-N 0.000 claims 60
- 229960000607 ziprasidone Drugs 0.000 claims 60
- 239000006186 oral dosage form Substances 0.000 claims 39
- 239000007787 solid Substances 0.000 claims 39
- 210000002966 serum Anatomy 0.000 claims 14
- 239000002552 dosage form Substances 0.000 claims 9
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 8
- 208000015114 central nervous system disease Diseases 0.000 claims 7
- 241000282412 Homo Species 0.000 claims 5
- 239000008247 solid mixture Substances 0.000 claims 5
- 229940100691 oral capsule Drugs 0.000 claims 4
- 238000013268 sustained release Methods 0.000 claims 4
- 239000012730 sustained-release form Substances 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 3
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims 3
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 230000003111 delayed effect Effects 0.000 claims 2
- 238000004090 dissolution Methods 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 238000001556 precipitation Methods 0.000 claims 2
- 229960003474 ziprasidone hydrochloride Drugs 0.000 claims 2
- ZCBZSCBNOOIHFP-UHFFFAOYSA-N ziprasidone hydrochloride hydrate Chemical compound [H+].O.[Cl-].C1=CC=C2C(N3CCN(CC3)CCC3=CC=4CC(=O)NC=4C=C3Cl)=NSC2=C1 ZCBZSCBNOOIHFP-UHFFFAOYSA-N 0.000 claims 2
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 238000013265 extended release Methods 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3494708P | 2008-03-07 | 2008-03-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009215293A JP2009215293A (ja) | 2009-09-24 |
| JP2009215293A5 true JP2009215293A5 (enExample) | 2012-04-12 |
Family
ID=40720011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009052853A Withdrawn JP2009215293A (ja) | 2008-03-07 | 2009-03-06 | 食物なしでジプラシドンを投与するための方法、剤形、およびキット |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110002989A1 (enExample) |
| EP (1) | EP2280711A1 (enExample) |
| JP (1) | JP2009215293A (enExample) |
| KR (1) | KR20100131477A (enExample) |
| CN (1) | CN102014910A (enExample) |
| AR (1) | AR070964A1 (enExample) |
| AU (1) | AU2009220925A1 (enExample) |
| BR (1) | BRPI0909818A2 (enExample) |
| CA (1) | CA2719115A1 (enExample) |
| IL (1) | IL207792A0 (enExample) |
| MX (1) | MX2010009844A (enExample) |
| RU (1) | RU2010135831A (enExample) |
| TW (1) | TW200950783A (enExample) |
| WO (1) | WO2009109844A1 (enExample) |
| ZA (1) | ZA201005905B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010082855A1 (en) * | 2009-01-15 | 2010-07-22 | Zaklady Farmaceutyczne Polpharma Sa | Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation |
| US9510148B2 (en) * | 2009-03-03 | 2016-11-29 | Mobilitie, Llc | System and method for wireless communication to permit audience participation |
| CN105492007A (zh) * | 2013-05-03 | 2016-04-13 | 欣达克斯制药公司 | 癌症治疗方法 |
| JP6153667B2 (ja) | 2013-07-30 | 2017-06-28 | ギリアード コネチカット， インコーポレイテッド | Ｓｋｙ阻害剤の製剤 |
| NZ715776A (en) | 2013-07-30 | 2017-04-28 | Gilead Connecticut Inc | Polymorph of syk inhibitors |
| JP6505705B2 (ja) * | 2013-12-05 | 2019-04-24 | アルライズ バイオシステムズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 経口投与用製剤の製造方法 |
| TWI735853B (zh) | 2013-12-23 | 2021-08-11 | 美商克洛諾斯生技有限公司 | 脾酪胺酸激酶抑制劑 |
| US10474345B2 (en) * | 2014-04-04 | 2019-11-12 | Shawn SHEY | User interfaces and methods for displaying content |
| BR112017005283A2 (pt) * | 2014-09-19 | 2017-12-12 | Procter & Gamble | processo para produção de um núcleo com um revestimento ativo |
| JP6796083B2 (ja) | 2015-06-09 | 2020-12-02 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ | カプセル中の薬剤の噴霧乾燥ディスパーションからの迅速な溶解を達成するための製剤 |
| WO2016198113A1 (en) | 2015-06-11 | 2016-12-15 | Alrise Biosystems Gmbh | Process for the preparation of drug loaded microparticles |
| CN107714669A (zh) * | 2016-08-11 | 2018-02-23 | 广东东阳光药业有限公司 | 齐拉西酮缓释剂及其制备方法 |
| US11384082B2 (en) | 2017-08-25 | 2022-07-12 | Kronos Bio, Inc. | Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors |
| CN113950479A (zh) | 2019-02-22 | 2022-01-18 | 克洛诺斯生物股份有限公司 | 作为syk抑制剂的缩合吡嗪的固体形式 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002309172A1 (en) * | 2001-06-22 | 2003-01-08 | Pfizer Products Inc. | Pharmaceutical compositions containing polymer and drug assemblies |
| CN1874761A (zh) * | 2003-09-02 | 2006-12-06 | 辉瑞产品公司 | 齐拉西酮的持续释放剂型 |
| US7825106B2 (en) * | 2003-09-03 | 2010-11-02 | Agi Therapeutics Ltd. | Modified release formulations and methods of treating inflammatory bowel disease |
| US20050163858A1 (en) * | 2003-12-31 | 2005-07-28 | Garth Boehm | Ziprasidone formulations |
| WO2005123086A2 (en) * | 2004-06-11 | 2005-12-29 | Dr. Reddy's Laboratories Ltd. | Ziprasidone dosage form |
| KR20080024206A (ko) * | 2005-06-20 | 2008-03-17 | 엘란 파마 인터내셔널 리미티드 | 아릴-헤테로시클릭 화합물을 함유하는 나노입자형 조절방출 조성물 |
-
2009
- 2009-03-04 EP EP09717510A patent/EP2280711A1/en not_active Withdrawn
- 2009-03-04 BR BRPI0909818A patent/BRPI0909818A2/pt not_active IP Right Cessation
- 2009-03-04 US US12/920,400 patent/US20110002989A1/en not_active Abandoned
- 2009-03-04 MX MX2010009844A patent/MX2010009844A/es not_active Application Discontinuation
- 2009-03-04 KR KR1020107022343A patent/KR20100131477A/ko not_active Ceased
- 2009-03-04 CN CN2009801164839A patent/CN102014910A/zh active Pending
- 2009-03-04 AU AU2009220925A patent/AU2009220925A1/en not_active Abandoned
- 2009-03-04 CA CA2719115A patent/CA2719115A1/en not_active Abandoned
- 2009-03-04 TW TW098106972A patent/TW200950783A/zh unknown
- 2009-03-04 RU RU2010135831/15A patent/RU2010135831A/ru not_active Application Discontinuation
- 2009-03-04 WO PCT/IB2009/000442 patent/WO2009109844A1/en not_active Ceased
- 2009-03-06 AR ARP090100819A patent/AR070964A1/es not_active Application Discontinuation
- 2009-03-06 JP JP2009052853A patent/JP2009215293A/ja not_active Withdrawn
-
2010
- 2010-08-18 ZA ZA2010/05905A patent/ZA201005905B/en unknown
- 2010-08-24 IL IL207792A patent/IL207792A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009215293A5 (enExample) | ||
| RU2010135831A (ru) | Способы, лекарственные формы и наборы для введения зипрасидона без пищи | |
| JP2017128614A5 (enExample) | ||
| JP2009523175A5 (enExample) | ||
| JP2019517542A5 (enExample) | ||
| RU2019134558A (ru) | Композиции и способы лечения анемии | |
| WO2013079964A1 (en) | Combination treatment of cancer | |
| CN103096878B (zh) | 包含苯并咪唑衍生物的固体药物组合物 | |
| JP2018505158A5 (enExample) | ||
| JP2016516016A5 (enExample) | ||
| JP2020530831A5 (enExample) | ||
| JP2015515984A5 (enExample) | ||
| JP2019529570A5 (enExample) | ||
| JP2020500864A5 (enExample) | ||
| JP2014533701A5 (enExample) | ||
| JP2007500176A5 (enExample) | ||
| JP2019534330A5 (enExample) | ||
| EP3856177A1 (en) | Grapiprant unit dosage forms | |
| JP2016512247A5 (enExample) | ||
| KR20160011205A (ko) | 히드로코티손을 포함하는 조성물 | |
| CN105919979A (zh) | 一种替曲朵辛肠溶缓释微丸、制备方法及其应用 | |
| JP2018505901A5 (enExample) | ||
| CN102485228B (zh) | 一种药物组合物及其用途 | |
| CN105106243A (zh) | Bacteroides thetaiotaomicron VPI-5482在制备治疗或预防肥胖症药物中的应用 | |
| JP2010529125A5 (enExample) |